SCP-857
Safe
~
medium confidence
SCP-857
Expected annual
$2.6M
One-time setup
$5.4M
Annual recurring
$2.5M
Personnel
17
Estimated capital/setup costs are approximately $5.39M driven by site construction, lab buildout and contingency funding; ongoing annual operations are approximately $2.49M/year driven primarily by staffing, logistics, and recurring research/monitoring costs.
One-Time Capital Costs
Total: $5.4M
Annual Recurring Costs
Total: $2.5M/yr
Cost Scenarios
📊
Baseline
(baseline)
$2.5M/yr
Normal operational year with routine monitoring, research campaigns and no significant containment incidents.
no_incident
routine_research
scheduled_maintenance
🚨
Minor Incident
$2.6M/yr
Small containment breach or equipment failure requiring targeted repairs, overtime, localized recapture and additional consumables/amnestic usage.
localized_breach
equipment_failure
trespasser_incident
🚨
Major Breach
$3.5M/yr
Significant breach requiring multi-day recovery operations, sustained helicopter lifts, large-scale repairs and legal/cover response.
multi-day_breach
widespread_specimen_escape
major_equipment_loss
🚨
Catastrophic Breach
$7.5M/yr
Catastrophic containment failure or exposure requiring evacuation, large-scale eradication/relocation and major legal/PR/compensation operations.
widespread_exposure
political_exposure
need_for_evacuate_or_eradicate
Personnel
17 total
| Role | Count | Notes |
|---|---|---|
| Research Scientist | 5 | [#10] Field xenobiologists, molecular biologists, veterinarians/pathologists; count set to match budgeted researcher allocation within staff wages. |
| Security Officer / MTF Agent | 8 | [#11] 24/7 perimeter security with rotations; minimum staffing aligned with analyst note (8–12) while fitting wage budget. |
| Support Staff (Medic/Technician/Cook/Maintenance/Admin) | 4 | [#12] Medical tech/EMT, lab technicians, mechanics, logistics coordinator and admin support; consolidated to fit overall staffing budget. |
Confidence Notes
Estimates are based on analyst ranges and typical field-site costs; many items (biosafety level chosen, frequency/scale of research campaigns, contingency usage and amnestic pricing) remain uncertain, producing moderate confidence.